Ex-CDC Chief Attacks Trump’s HHS Nominee RFK Jr.
Submitted by MAGA Student
Posted 4 days ago
**Shocking Claims: Ex-CDC Chief Attacks Trump’s HHS Nominee RFK Jr.**
In a move that has sparked fierce debate, former CDC chief Richard Besser criticized President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS), calling it “chilling” and expressing concern over Kennedy's advocacy for vaccine safety.
Besser’s comments, made during a CNN appearance, reflect the desperation of those within the establishment who oppose any challenge to their narrative on vaccines. He suggested that Kennedy’s focus on vaccine safety undermines public health, claiming that hesitancy about vaccines could have dangerous consequences.
What Besser and others fail to recognize, however, is that Kennedy is not "anti-vaxx." He has repeatedly clarified that his position advocates for more stringent safety protocols and rigorous testing of vaccines, a stance that aligns with many parents who are rightly concerned about the ingredients and testing of vaccines administered to their children.
This nomination has sent shockwaves through the pharmaceutical industry, resulting in significant stock drops for major vaccine manufacturers including Moderna and BioNTech, possibly indicating that Kennedy's influence could usher in a new era of accountability in vaccine safety.
Critics like Besser often cloak their attacks in the guise of public health, but Kennedy’s appointment could signify a much-needed shift towards transparency and consumer choice in healthcare. The unease from pharmaceutical executives, as evidenced by their emergency conference following Trump's election victory, suggests that they are worried about losing their grip on the public narrative, especially with a candidate like Kennedy who has a reputation for challenging conventional wisdom.
The American public deserves leaders who prioritize truth and patient safety over the interests of big pharma. Trump's choice to nominate Kennedy for a critical cabinet position indicates a willingness to confront the entrenched interests that compromise the health of many Americans.
As the media continues to vilify figures like RFK Jr., it's vital for the public to consider what this backlash truly signifies. Are we witnessing a defensive reaction from those threatened by transparency in healthcare?
In light of these developments, it's crucial to support leaders who are not afraid to question the status quo and advocate for the well-being of families across the nation. Kennedy's nomination could mark a pivotal step toward a future where health policies are driven by safety and informed consent rather than corporate profits.
Sources:
infowars.com
zerohedge.com
dailywire.com
In a move that has sparked fierce debate, former CDC chief Richard Besser criticized President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS), calling it “chilling” and expressing concern over Kennedy's advocacy for vaccine safety.
Besser’s comments, made during a CNN appearance, reflect the desperation of those within the establishment who oppose any challenge to their narrative on vaccines. He suggested that Kennedy’s focus on vaccine safety undermines public health, claiming that hesitancy about vaccines could have dangerous consequences.
What Besser and others fail to recognize, however, is that Kennedy is not "anti-vaxx." He has repeatedly clarified that his position advocates for more stringent safety protocols and rigorous testing of vaccines, a stance that aligns with many parents who are rightly concerned about the ingredients and testing of vaccines administered to their children.
This nomination has sent shockwaves through the pharmaceutical industry, resulting in significant stock drops for major vaccine manufacturers including Moderna and BioNTech, possibly indicating that Kennedy's influence could usher in a new era of accountability in vaccine safety.
Critics like Besser often cloak their attacks in the guise of public health, but Kennedy’s appointment could signify a much-needed shift towards transparency and consumer choice in healthcare. The unease from pharmaceutical executives, as evidenced by their emergency conference following Trump's election victory, suggests that they are worried about losing their grip on the public narrative, especially with a candidate like Kennedy who has a reputation for challenging conventional wisdom.
The American public deserves leaders who prioritize truth and patient safety over the interests of big pharma. Trump's choice to nominate Kennedy for a critical cabinet position indicates a willingness to confront the entrenched interests that compromise the health of many Americans.
As the media continues to vilify figures like RFK Jr., it's vital for the public to consider what this backlash truly signifies. Are we witnessing a defensive reaction from those threatened by transparency in healthcare?
In light of these developments, it's crucial to support leaders who are not afraid to question the status quo and advocate for the well-being of families across the nation. Kennedy's nomination could mark a pivotal step toward a future where health policies are driven by safety and informed consent rather than corporate profits.
Sources:
infowars.com
zerohedge.com
dailywire.com
Latest News